期刊投稿分析：ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY

期刊名称：ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY

期刊中文名：《 人工细胞纳米医学和生物技术 》

ISSN: 2169-1401

2018年影响因子：4.462，Q1

出版周期：6期/年

年发文量：560

出版公司：TAYLOR & FRANCIS LTD, 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND出版

中国人发表情况：2018年发表中国论文180篇。

审稿周期：1.6月

期刊简介：This journal covers artificial cells, blood substitutes, and immobilization biotechnology including gene therapy, cell therapy, enzyme therapy, bioencapsulation, microencapsulation, nanocapsules, nanoparticles, artificial organs, biomaterials, hybrid artificial organs, drug delivery systems, hemoperfusion, sorbents, immunosorbents, and biotechnology. The emphasis is on interdisciplinary interactions from basic and applied research to clinical trials. For a complete listing of topics covered, see the Instructions to Authors at the end of this issue.

期刊网站：https://www.tandfonline.com/loi/ianb20

投稿链接：https://mc.manuscriptcentral.com/labb

收费情况：$1950